Bayer-Monsanto Deal Would Be Tough Sell For Regulators

Law360, New York (May 20, 2016, 7:43 PM EDT) -- The already-heightened sensitivity of antitrust regulators to large corporate tie-ups would pose a major hurdle to German pharmaceutical and chemical giant Bayer's potential acquisition of U.S. agrochemical company Monsanto, with the quickly consolidating agrochemical space making the industry's latest megadeal an even tougher sale, experts say.

Bayer AG confirmed Thursday that the companies' executives had met to discuss a potential deal, after Monsanto Co. revealed in a separate statement that it was looking over an unsolicited bid from the German company. Neither disclosed the terms of the...
To view the full article, register now.